// App-Quantinova.ai

: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: DOES MINIMAL RESIDUAL DISEASE BEFORE TRANSPLANTATION MATTER FOR LONG TERM OUTCOME?

Researchers

Presenter

  • Irati Ormazabal Velez

Principal Investigators

  • Angela Figuera Alvarez

  • Juan Luis Steegmann Olmedillas

  • Rafael De la Cmara Llanza

  • Ana Garca-Noblejas Moya

Medical Centers

  • Hematology and Hemotherapy,Hospital Universitario Infanta Leonor,Madrid,Spanien

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved